{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:42:20Z","timestamp":1767894140071,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1245\/s10434-020-09232-9","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T19:02:34Z","timestamp":1603047754000},"page":"4996-5004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["CRS\/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative"],"prefix":"10.1245","volume":"27","author":[{"given":"David","family":"Roife","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin D.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Y.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Staley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Leiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jula","family":"Veerapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callisia","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Pokrzywa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byrne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Blakely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Laskowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dessureault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-2238","authenticated-orcid":false,"given":"Sean P.","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,18]]},"reference":[{"key":"9232_CR1","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1245\/s10434-014-3803-6","volume":"21","author":"JT Miura","year":"2014","unstructured":"Miura JT, Johnston FM, Gamblin TC, et al. Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol. 2014;21:3947\u201353.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","volume":"35","author":"H Yano","year":"2009","unstructured":"Yano H, Moran BJ, Cecil TD, et al. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol (EJSO). 2009;35:980\u20135.","journal-title":"Eur J Surg Oncol (EJSO)."},{"key":"9232_CR3","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","volume":"36","author":"V Panou","year":"2018","unstructured":"Panou V, Gadiraju M, Wolin A, et al. Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol. 2018;36:2863\u201371.","journal-title":"J Clin Oncol."},{"key":"9232_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985\u201390.","journal-title":"Ann Oncol."},{"key":"9232_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","volume":"8","author":"A Garc\u00eda-Fadrique","year":"2017","unstructured":"Garc\u00eda-Fadrique A, Mehta A, Mohamed F, et al. Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review. J Gastrointest Oncol. 2017;8:915\u201324.","journal-title":"J Gastrointest Oncol."},{"key":"9232_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/oemed-2019-105826","volume":"76","author":"D Consonni","year":"2019","unstructured":"Consonni D, Calvi C, Matteis SD, et al. Peritoneal mesothelioma and asbestos exposure: a population-based case\u2013control study in Lombardy, Italy. Occup Environ Med. 2019;76:545\u201353.","journal-title":"Italy. Occup Environ Med."},{"key":"9232_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jso.21177","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol. 2009;99:109\u201313.","journal-title":"J Surg Oncol."},{"key":"9232_CR8","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. JCO. 2009;27:6237\u201342.","journal-title":"JCO."},{"key":"9232_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/02656736.2018.1434902","volume":"34","author":"SNS Gilani","year":"2018","unstructured":"Gilani SNS, Mehta A, Garcia-Fadrique A, et al. Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival. Int J Hyperth. 2018;34:578\u201384.","journal-title":"Int J Hyperthermia."},{"key":"9232_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1200\/JOP.2016.011908","volume":"12","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH, Turaga KK, Alexander HR, et al. Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy. JOP. 2016;12:928\u201335.","journal-title":"JOP."},{"key":"9232_CR11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","volume":"67","author":"BW Loggie","year":"2001","unstructured":"Loggie BW, Fleming RA, McQuellon RP, et al. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg. 2001;67:999\u20131003.","journal-title":"Am Surg."},{"key":"9232_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/02656736.2017.1320591","volume":"33","author":"KK Turaga","year":"2017","unstructured":"Turaga KK, Deraco M, Alexander HR. Current management strategies for peritoneal mesothelioma. Int J Hyperth. 2017;33:579\u201381.","journal-title":"Int J Hyperthermia."},{"key":"9232_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1200\/JOP.2016.016576","volume":"12","author":"HL Kindler","year":"2016","unstructured":"Kindler HL. The challenge of defining treatment standards for a rare disease: malignant peritoneal mesothelioma. JOP. 2016;12:936\u20137.","journal-title":"JOP."},{"key":"9232_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004230050246","volume":"384","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon\u2019s role. Langenbeck\u2019s Arch Surg. 1999;384:576\u201387.","journal-title":"Langenbeck\u2019s Arch Surg."},{"key":"9232_CR15","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1245\/s10434-017-6106-x","volume":"24","author":"DR Heller","year":"2017","unstructured":"Heller DR, Chiuzan C, Taub RN, et al. Recurrence of optimally treated malignant peritoneal mesothelioma with cytoreduction and heated intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24:3818\u201324.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08482-x","author":"BD Powers","year":"2020","unstructured":"Powers BD, Felder S, Veerapong J, et al. Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is not associated with prohibitive complications: results of a multiinstitutional retrospective study. Ann Surg Oncol. 2020. https:\/\/doi.org\/10.1245\/s10434-020-08482-x.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","volume":"24","author":"NC Levinsky","year":"2020","unstructured":"Levinsky NC, Morris MC, Wima K, et al. Should we be doing cytoreductive surgery with hipec for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC collaborative. J Gastrointest Surg. 2020;24:155\u201364.","journal-title":"J Gastrointest Surg."},{"key":"9232_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","volume":"219","author":"EW Beal","year":"2020","unstructured":"Beal EW, Ahmed A, Grotz T, et al. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219:478\u201383.","journal-title":"Am J Surg."},{"key":"9232_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11605-019-04463-y","volume":"24","author":"TC Lee","year":"2020","unstructured":"Lee TC, Wima K, Sussman JJ, et al. Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a US HIPEC collaborative study. J Gastrointest Surg. 2020;24:165\u201376.","journal-title":"J Gastrointest Surg."},{"key":"9232_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"key":"9232_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg."},{"key":"9232_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","volume":"32","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH, Yan TD, Stuart OA, et al. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol (EJSO). 2006;32:686\u201391.","journal-title":"Eur J Surg Oncol (EJSO)."},{"key":"9232_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg."},{"key":"9232_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1245\/s10434-013-3341-7","volume":"21","author":"J Wong","year":"2014","unstructured":"Wong J, Koch AL, Deneve JL, et al. Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience. Ann Surg Oncol. 2014;21:1480\u20136.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander","year":"2013","unstructured":"Alexander HR, Bartlett DL, Pingpank JF, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013;153:779\u201386.","journal-title":"Surgery."},{"key":"9232_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ejso.2017.01.009","volume":"43","author":"PH Sugarbaker","year":"2017","unstructured":"Sugarbaker PH, Chang D. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. Eur J Surg Oncol (EJSO). 2017;43:1228\u201335.","journal-title":"Eur J Surg Oncol (EJSO)."},{"key":"9232_CR27","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1245\/s10434-012-2791-7","volume":"20","author":"PL Wagner","year":"2013","unstructured":"Wagner PL, Austin F, Maduekwe U, et al. Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival. Ann Surg Oncol. 2013;20:1056\u201362.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","volume":"23","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, et al. Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2016;23:833\u201341.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR29","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1245\/s10434-008-0105-x","volume":"15","author":"J Franko","year":"2008","unstructured":"Franko J, Gusani NJ, Holtzman MP, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008;15:3065\u201372.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1245\/s10434-013-3393-8","volume":"21","author":"MS Leapman","year":"2014","unstructured":"Leapman MS, Jibara G, Tabrizian P, et al. Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study. Ann Surg Oncol. 2014;21:1153\u20138.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1245\/s10434-013-3354-2","volume":"21","author":"KI Votanopoulos","year":"2014","unstructured":"Votanopoulos KI, Randle RW, Craven B, et al. Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21:868\u201374.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1245\/s10434-014-4083-x","volume":"22","author":"B Franssen","year":"2015","unstructured":"Franssen B, Tabrizian P, Weinberg A, et al. Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Ann Surg Oncol. 2015;22:1639\u201344.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR33","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1245\/s10434-014-3891-3","volume":"21","author":"S Ahmed","year":"2014","unstructured":"Ahmed S, Levine EA, Randle RW, et al. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21:4226\u201331.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR34","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1245\/s10434-007-9475-8","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Nonaka D, et al. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol. 2007;14:2790\u20137.","journal-title":"Ann Surg Oncol."},{"key":"9232_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jso.10081","volume":"79","author":"S Gonz\u00e1lez-Moreno","year":"2002","unstructured":"Gonz\u00e1lez-Moreno S, Yan H, Alcorn KW, et al. Malignant transformation of \u201cbenign\u201d cystic mesothelioma of the peritoneum. J Surg Oncol. 2002;79:243\u201351.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09232-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:34:19Z","timestamp":1696898059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09232-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,18]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9232"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09232-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,18]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}